Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Imatinib Mesylate × Clear all

NCT00045669 2019-02-15

Imatinib Mesylate in Treating Patients With Salivary Gland Cancer

Phase 2 Completed

Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00485485 2012-08-07

Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer

Phase 2 Completed

7 enrolled 7 charts

Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT00180921 2007-09-26

Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

Phase 2 Unknown

Carcinoma, Adenoid Cystic, Head and Neck Neoplasms